Neurochemical abnormalities in unmedicated bipolar depression and mania: A 2D 1H MRS investigation

Psychiatry Research - Neuroimaging

Volumn 213, Issue 3, 2013, Pages 235-241

  Xu, Jun ^a,b   Dydak, Ulrike ^a,b   Harezlak, Jaroslaw ^a   Nixon, Jonathan ^b   Dzemidzic, Mario ^a   Gunn, Abigail D ^a   Karne, Harish S ^a   Anand, Amit ^a,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PURDUE UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Bipolar disorder; Depression; Glutamate; Lactate; Mania; MRS

Indexed keywords

CREATINE; GLUTAMIC ACID; GLUTAMINE;

ADULT; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR MANIA; BRAIN REGION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MALE; METABOLITE; NEUROCHEMISTRY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; POSTERIOR CINGULATE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCORING SYSTEM; THALAMUS;

EID: 84880725997     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2013.02.008     Document Type: Article

References (49)

1. Anand A., Charney D.S. Abnormalities in catecholamines and pathophysiology of bipolar disorder. Bipolar Disorder: Basic Mechanisms and Therapeutic Implications 2000, Marcel Dekker, New York, pp. 59-94. J.C. Soares, S. Gershon (Eds.).
2. Anand A., Li Y., Wang Y., Lowe M.J., Dzemidzic M. Resting state corticolimbic connectivity abnormalities in unmedicated bipolar disorder and unipolar depression. Psychiatry Research-Neuroimaging 2009, 171:189-198.
3. Berman R.M., Cappiello A., Anand A., Oren D.A., Heninger G.R., Charney D.S., Krystal J.H. Antidepressant effects of ketamine in depressed patients. Biological Psychiatry 2000, 47:351-354.
4. Bhagwagar Z., Wylezinska M., Jezzard P., Evans J., Ashworth F., Sule A., Matthews P.M., Cowen P.J. Reduction in occipital cortex [gamma]-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biological Psychiatry 2007, 61:806-812.
5. Brambilla P., Stanley J.A., Nicoletti M.A., Sassi R.B., Mallinger A.G., Frank E., Kupfer D., Keshavan M.S., Soares J.C. 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. Journal of Affective Disorders 2005, 86:61-67.
6. Brambilla P., Stanley J.A., Sassi R.B., Nicoletti M.A., Mallinger A.G., Keshavan M.S., Soares J.C. 1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration. Neuropsychopharmacology 2004, 29:1918-1924.
7. Brown T.R., Kincaid B.M., Ugurbil K. NMR chemical shift imaging in three dimensions. Proceedings of the National Academy of Sciences 1982, 79:3523-3526.
8. Cecil K.M., DelBello M.P., Morey R., Strakowski S.M. Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disorders 2002, 4:357-365.
9. Critchley H.D., Mathias C.J., Josephs O., O'Doherty J., Zanini S., Dewar B.K., Cipolotti L., Shallice T., Dolan R.J. Human cingulate cortex and autonomic control: converging neuroimaging and clinical evidence. Brain 2003, 126:2139-2152.
10. Cummings J.L. Anatomic and behavioral aspects of frontal-subcortical circuits. Annals of the New York Academy of Sciences 1995, 769:1-13.
11. Dager S.R., Corrigan N.M., Richards T.L., Posse S. Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders. Topics in Magnetic Resonance Imaging 2008, 19:81-96.
12. Dager S.R., Friedman S.D., Parow A., Demopulos C., Stoll A.L., Lyoo I.K., Dunner D.L., Renshaw P.F. Brain metabolic alterations in medication-free patients with bipolar disorder. Archives of General Psychiatry 2004, 61:450-458.
13. Deicken R.F., Eliaz Y., Feiwell R., Schuff N. Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder. Psychiatry Research: Neuroimaging 2001, 106:35-45.
14. Etkin A., Egner T., Peraza D.M., Kandel E.R., Hirsch J. Resolving emotional conflict: a role for the rostral anterior cingulate cortex in modulating activity in the amygdala. Neuron 2006, 51:871-882.
15. Frey B.N., Stanley J.A., Nery F.G., Monkul E.S., Nicoletti M.A., Chen H.H., Hatch J.P., Caetano S.C., Ortiz O., Kapczinski F., Soares J.C. Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study. Bipolar Disorders 2007, 9:119-127.
16. Friedman S.D., Dager S.R., Parow A., Hirashima F., Demopulos C., Stoll A.L., Lyoo I.K., Dunner D.L., Renshaw P.F. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder. Biological Psychiatry 2004, 56:340-348.
17. Frye M.A., Thomas M.A., Yue K., Binesh N., Davanzo P., Ventura J., O'Neill J., Guze B., Curran J.G., Mintz J. Reduced concentrations of N-acetylaspartate (NAA) and the NAA-creatine ratio in the basal ganglia in bipolar disorder: a study using 3-Tesla proton magnetic resonance spectroscopy. Psychiatry Research: Neuroimaging 2007, 154:259-265.
18. Frye M.A., Watz J., Banakar S. Increased anterior cingulate/medial prefrontal cortex glutmate and creatine in bipolar depression. Neuropsychopharmacology 2007, 32:2490-2499.
19. Gallelli K.A., Wagner C.M., Karchemskiy A., Howe M., Spielman D., Reiss A., Chang K.D. N-acetylaspartate levels in bipolar offspring with and at high-risk for bipolar disorder. Bipolar Disorders 2005, 7:589-597.
20. Garakani A., Charney D.S., Anand A. Abnormalities in catecholamines and pathophysiology of bipolar disorder. Bipolar Disorders Pathophsyiology and Treatment 2007, Marcel Dekker, New York. J.C. Soares, A.S. Young (Eds.).
21. Greicius M.D., Flores B.H., Menon V., Glover G.H., Solvason H.B., Kenna H., Reiss A.L., Schatzberg A.F. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biological Psychiatry 2007, 62:429-437.
22. Hamilton, M., 1976. Hamilton Depression Scale, in: Guy, W. (Ed.), ECDEDU Asssessment Manual for Psychopharmacology, Revised Edition, US Department of Health, Eonducation, and Welfare Publication. National Institute of Mental Health, Rockville, MD, pp. 179-192.
23. Kato T., Murashita J., Kamiya A., Shioiri T., Kato N., Inubushi T. Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation with white matter hyperintensity. European Archives of Psychiatry and Clinical Neurosciences 1998, 248:301-306.
24. Kato T., Shioiri T., Murashita J., Hamakawa H., Takahashi Y., Inubushi T., Takahashi S. Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS. Psychological Medicine 1995, 25:557-566.
25. Kato T., Shioiri T., Takahashi S., Inubushi T. Measurement of brain phosphoinositide metabolism in bipolar patients using in vivo 31P-MRS. Journal of Affective Disorders 1991, 22:185-190.
26. Kaufman R.E., Ostacher M.J., Marks E.H., Simon N.M., Sachs G.S., Jensen J.E., Renshaw P.F., Pollack M.H. Brain GABA levels in patients with bipolar disorder. Progress in Neuropsychopharmacology and Biological Psychiatry 2009, 33:427-434. Epub 2009; January 2010.
27. Kim H., McGrath B.M., Silverstone P.H. A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders--focus on magnetic resonance spectroscopy (MRS) studies. Human Psychopharmacology 2005, 20:309-326.
28. Krystal J.H., Belger A., D'Souza D.C., Anand A., Charney D.S., Aghajanian G.K., Moghaddam B. Therapeutic implications of the hyperglutamatergic effects of NMDA antagonists. Neuropsychopharmacology 1999, 21:S143-S157.
29. Michael N., Erfurth A., Pfleiderer B. Elevated metabolites within dorsolateral prefrontal cortex in rapid cycling bipolar disorder. Psychiatry Research: Neuroimaging 2009, 172:78-81.
30. Moore C.M., Breeze J.L., Gruber S.A., Babb S.M., Frederick B.B., Villafuerte R.A., Stoll A.L., Hennen J., Yurgelun-Todd D.A., Cohen B.M., Renshaw P.F. Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disorders 2000, 2:207-216.
31. Moore G.J., Galloway M.P. Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders. Psychopharmacology Bulletin 2002, 36:5-23.
32. Murashita J., Kato T., Shioiri T., Inubushi T., Kato N. Altered brain energy metabolism in lithium-resistant bipolar disorder detected by photic stimulated 31P-MR spectroscopy. Psychological Medicine 2000, 30:107-115.
33. Nurnberger J.I., Blehar M.C., Kaufmann C.A., York-Cooler C., Simpson S.G., Harkavy-Friedman J., Severe J.B., Malaspina D., Reich T. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Archives of General Psychiatry 1994, 51:849-859. discussion 863-844.
34. Perlis R.H., et al. Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study. Bipolar Disorders 2009, 11(4):391-400.
35. Provencher Estimation of metabolite concentrations from localized in-vivo proton NMR-spectra. Magnetic Resonance in Medicine 1993, 30:672-679.
36. Raichle M.E., MacLeod A.M., Snyder A.Z., Powers W.J., Gusnard D.A., Shulman G.L. A default mode of brain function. Proceedings of the National Academy of Sciences 2001, 98:676-682.
37. Senaratne R., Milne A.M., MacQueen G.M., Hall G.B. Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: a proton magnetic resonance spectroscopy study. Psychiatry Research: Neuroimaging 2009, 172:205-209.
38. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 1998, 59:22-33. quiz 34-57.
39. Silverstone P.H., Wu R.H., O'Donnell T., Ulrich M., Asghar S.J., Hanstock C.C. Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients. Human Psychopharmacology 2002, 17:321-327.
40. Stork C., Renshaw P.F. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Molecular Psychiatry 2005, 10:900-919.
41. Strakowski S.M., DelBello M.P., Adler C., Cecil D.M., Sax K.W. Neuroimaging in bipolar disorder. Bipolar Disorders 2000, 2:148-164.
42. Taber K.H., Wen C., Khan A., Hurley R.A. The limbic thalamus. Journal of Neuropsychiatry & Clinical Neurosciences 2004, 16:127-132.
43. Volz H.P., Rzanny R., Riehemann S., May S., Hegewald H., Preussler B., Hubner G., Kaiser W.A., Sauer H. 31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients. European Archives of Psychiatry & Clinical Neuroscience 1998, 248:289-295.
44. Winsberg M.E., Sachs N., Tate D.L., Adalsteinsson E., Spielman D., Ketter T.A. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biological Psychiatry 2000, 47:475-481.
45. Yildiz-Yesiloglu A., Ankerst D.P. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2006, 30:969-995.
46. Yildiz A., Demopulos C.M., Moore C.M., Renshaw P.F., Sachs G.S. Effect of lithium on phosphoinositide metabolism in human brain: a proton decoupled (31)P magnetic resonance spectroscopy study. Biological Psychiatry 2001, 50:3-7.
47. Young R.C., Schreiber M.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry 1978, 133:429-435.
48. Yüksel C., Öngür D. Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biological Psychiatry 2010, 68:785-794.
49. Zubieta J.-K., Huguelet P., Ohl L.E., Koeppe R.A., Kilbourn M.R., Carr J.M., Giordani B.J., Frey K.A. High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: sex differences and cognitive correlates. American Journal of Psychiatry 2000, 157:1619-1628.